These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 15363544

  • 1. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer.
    Fan CW, Fan HA, Hsu SH, Chan CC, Chen SY, Hsu YH, Chan EC.
    Cancer Lett; 2004 Oct 28; 214(2):181-8. PubMed ID: 15363544
    [Abstract] [Full Text] [Related]

  • 2. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
    Matsuoka H, Nagaya M, Tsukikawa S, Yanagi Y, Isogai A, Kubota S.
    Surgery; 2006 Sep 28; 140(3):387-95. PubMed ID: 16934600
    [Abstract] [Full Text] [Related]

  • 3. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A, Nagaya M, Matsuoka H, Watanabe T, Tsukikawa S, Kubota S.
    Surgery; 2007 Nov 28; 142(5):741-8. PubMed ID: 17981195
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung MS, Lim SJ, Park JG.
    Cancer Res; 2005 Apr 15; 65(8):3162-70. PubMed ID: 15833846
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of 5-fluorouracil applicability by multi-point collagen gel droplet embedded drug sensitivity test.
    Ochiai T, Nishimura K, Noguchi H, Kitajima M, Tsuruoka Y, Takahashi Y.
    Oncol Rep; 2005 Jul 15; 14(1):201-5. PubMed ID: 15944790
    [Abstract] [Full Text] [Related]

  • 6. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M, Nishibori H, Hasegawa H, Ishii Y, Endo T, Kubota T, Kitajima M, Kitagawa Y.
    Oncol Rep; 2008 Nov 15; 20(5):1165-72. PubMed ID: 18949417
    [Abstract] [Full Text] [Related]

  • 7. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA, Pettiford BL, Schuchert MJ, Parker R, Ricketts WA, Luketich JD, Landreneau RJ.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2848-55. PubMed ID: 19609620
    [Abstract] [Full Text] [Related]

  • 8. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.
    Oncol Rep; 2006 Apr 15; 15(4):875-82. PubMed ID: 16525674
    [Abstract] [Full Text] [Related]

  • 9. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
    Han Y, Bu LM, Ji X, Liu CY, Wang ZH.
    Chin J Dig Dis; 2005 Apr 15; 6(2):82-6. PubMed ID: 15904426
    [Abstract] [Full Text] [Related]

  • 10. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Apr 15; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 11. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
    Calviello G, Di Nicuolo F, Serini S, Piccioni E, Boninsegna A, Maggiano N, Ranelletti FO, Palozza P.
    Cancer Chemother Pharmacol; 2005 Jan 15; 55(1):12-20. PubMed ID: 15365767
    [Abstract] [Full Text] [Related]

  • 12. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
    Jetté L, Bissoon-Haqqani S, Le François B, Maroun JA, Birnboim HC.
    Anticancer Res; 2008 Jan 15; 28(4B):2175-80. PubMed ID: 18751392
    [Abstract] [Full Text] [Related]

  • 13. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK, Srdić T, Radulović S.
    J BUON; 2007 Jan 15; 12(1):71-6. PubMed ID: 17436405
    [Abstract] [Full Text] [Related]

  • 14. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F.
    Eur J Cancer; 2009 Aug 15; 45(12):2219-27. PubMed ID: 19524433
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.
    Anticancer Res; 2007 Aug 15; 27(2):851-6. PubMed ID: 17465211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
    Zhou ZW, Wan DS, Wang GQ, Ren JQ, Lu ZH, Tang SX, Ye YL, Chen G, Lin SX.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar 15; 9(2):161-4. PubMed ID: 16555161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.